- Home
- ABT
as 02-21-2025 4:00pm EST
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
| Founded: | 1888 | Country: | United States |
| Employees: | N/A | City: | ABBOTT PARK |
| Market Cap: | 221.0B | IPO Year: | N/A |
| Target Price: | $131.41 | AVG Volume (30 days): | 6.5M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.64 | EPS Growth: | 134.36 |
| 52 Week Low/High: | $99.71 - $135.41 | Next Earning Date: | 04-16-2025 |
| Revenue: | $41,950,000,000 | Revenue Growth: | 4.59% |
| Revenue Growth (this year): | 6.71% | Revenue Growth (next year): | 7.45% |
Stock Insider Trading Activity of Abbott Laboratories (ABT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Ford Robert B | ABT | CHAIRMAN AND CEO | Feb 5 '25 | Sell | $131.17 | 285,388 | $37,435,200.12 | 220,059 | |
| Salvadori Daniel Gesua Sive | ABT | EXECUTIVE VICE PRESIDENT | Jan 30 '25 | Sell | $128.50 | 23,771 | $3,054,573.50 | 125,697 | |
| ALLEN HUBERT L | ABT | EXECUTIVE VICE PRESIDENT | Jan 29 '25 | Sell | $128.21 | 189,788 | $24,342,303.62 | 184,806 | |
| Morrone Louis H. | ABT | EXECUTIVE VICE PRESIDENT | Jan 28 '25 | Sell | $127.39 | 2,644 | $336,819.16 | 0 |
Latest Abbott Laboratories News
ABT Breaking Stock News: Dive into ABT Ticker-Specific Updates for Smart Investing
ACCESS Newswire
18 hours ago
Showing Students the World of Possibilities in STEM
Zacks
a day ago
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know
GuruFocus.com
3 days ago
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories
Insider Monkey
5 days ago
Abbott Laboratories (ABT): Among the Best Drug Stocks to Buy Now
Benzinga
8 days ago
If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?
Simply Wall St.
8 days ago
Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger
Insider Monkey
9 days ago
Jim Cramer on Abbott Laboratories (ABT): ‘Big Position For The Trust’
Motley Fool
9 days ago
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Compare ABT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABT Abbott Laboratories - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.